Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, today announced the publication of three abstracts regarding its SMARCA ...
AP: Soon, the ballots will be cast, the polls will close and a campaign marked by assassination attempts, animosity and anxiety will come to an end. But for U.S. adversaries, the work to meddle with ...